Table 3.
Classification | Gut microbiota | Enterobacterial metabolic enzyme | Substrate | End-product | Changes | Ref. |
---|---|---|---|---|---|---|
Flavonoids |
Clostridium sp. strain HGH6; Lactobacillus sp. Niu-O16 |
Dihydrodaidzein reductase; tetrahydrodaidzein reductase |
Daidzein | Dihydrodaidzein; tetrahydrodaidzein |
Anti-osteoporosis↑ | Wang et al. (2007) and Heng et al. (2019) |
Aeroto Niu-O16 | NA | Genistein | Dihydrogenistein | Bioavailability↑ | Mace et al. (2019) | |
Rat gut microbes E. ramulus |
Flavone reductase | Quercetin | Kaempferol; taxifolin |
Bioavailability↑ | Qin et al. (2017) | |
E. ramulus | Flavanone-/flavanonol-cleaving reductase | Xanthohumol; O-desmethylxanthohumol |
α, β-dihydroxanthohumol; O-desmethyl-α, β-dihydroxanthohumol |
Anti-bacterial↑ | Paraiso et al. (2019) | |
Alkaloids | Mouse gut microbes | Nitroreductase | BBR; coptisine |
dhBBR; hydrogenated berberine |
Bioavailability↑ anti-inflammatory↑ |
Feng et al. (2015) and Cui et al. (2018) |
Mouse gut microbes | NA | BBR | Oxyberberine | Anti-fungal↑ | Li C. et al. (2020) | |
Mouse/human gut microbes | NA | Avenanthramide-C | Dihydroavenanthramide-C | Anti-inflammation↑ anti-atherogenesis↑ |
Wang P. et al. (2015) | |
Phenolic acids | Human gut microbes | NA | CAA | Dihydrocaffeic acid | Bioavailability↑ | Gonthier et al. (2006) and García-Villalba et al. (2020) |
Rat gut microbes | NA | Isoferulic acid | Dihydrocaffeic acid | Anti-oxidant↑ anti-apoptosis↑ |
Kay et al. (2017) | |
Rat gut microbes | NA | Dansensu | 3-phenyl-2-hydroxy propionic acid; 3-(3,4-dihydroxy phenyl) 2-acrylic acid; 3-(3,4-dihydroxy phenyl)-propionate |
Bioavailability↑ | Gu et al. (2014) | |
Gordonibacter urolithinfaciens | Catechol-dehydroxylase | Chlorogenic acid; rosmarinic acid |
Dihydro-chlorogenic acid; dihydro-rosmarinic acid |
Bioavailability↑ | García-Villalba et al. (2020) | |
Terpenoids | Ruminococcus sp. po1-3 | 3β-hydroxysteroid dehydrogenase | Glycyrrhetinic acid | 3-oxo-glycyrrhetinic acid | Anti-inflammatory↑ | |
Anthraquinone | Human gut microbes; Streptococcus spp. |
NA | Sennoside-8-O-monoglycoside | Rhubaranthrone | Purgation↑ | Hattori et al. (1988) and Matsumoto et al. (2012) |
Stilbenes | Slackia equolifaciens; Eggerthella lenta ATCC 4305 | NA | Resveratrol | Dihydroresveratrol | Anti-oxidant↑ | Jung et al. (2009), Bode et al. (2013) and Pallauf et al. (2019) |
Diketones |
E. coli strain K-12; E. fergusonii ATCC 35469; E. coli strains ATCC 8739 and DH10B |
CurA | Curcumin | DHC; THC |
Anti-oxidant↑ lipid-lowering↑ |
Hassaninasab et al. (2011) and Tan et al. (2014) |
Steroids | Eubacterium lenta | Cardiac glycoside reductase | Digoxin | Dihydrodigoxin | Bioavailability↓ | Kumar et al. (2018) |
Other classes | Human gut microbes | NA | Aristolochic acid | Aristololactams | Anti-cancer↑ | Feng et al. (2019) |